The invention provides compounds of the formula: ##STR1##

and pharmaceutically acceptable salts or prodrugs thereof, wherein m, p, q, r, A, E, X, Y, R1, R4, R5, R6, R7, R8, R9 and are as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for using compounds of formula I.


< Transgenic expression from a SOCS-3 promoter in vertebrate cells

< Morpholine derivatives as antagonists of orexin receptors

> Polycyclic guanine derivative phosphodiesterase V inhibitors

> 5-substituted 2-aryl-4-pyrimidinones

~ 00207